About Jonathan Kagan
Jonathan Kagan is ai3Bio's scientific co-founder and distinguished scientist. ai3Bio is developing lipid nanoparticle and antibody therapies that remove the T cells that drive autoimmune disease. He is also the Marian R. Neutra, Ph.D. Professor of Pediatrics at Harvard Medical School. He directs Basic Research and holds the Shwachman Chair in Gastroenterology at Boston Children's Hospital.
He previously served as president of Corner Therapeutics, which he co-founded, and sat on its board of directors.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Jonathan Kagan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jonathan Kagan works with at each company, as listed on that company's latest Form D.
